$VYGR insider trading
Over the last 12 months, Voyager Therapeutics insiders reported no purchases and 12 sales totaling $335K across SEC Form 4 filings. 75% of those filings were made under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- — 0 events
- Sold · 12m
- $335K 12 events
- Events · 12m
- 12 Form 4 filings, grouped
- Insiders · 12m
- 4 distinct reporters
- 10b5-1 share
- 75% of events, not dollars
All insider trades
Scroll the table sideways for price, value and marks.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Apr 2, 2026 | Sandrock AlfredPresident and CEO · O·D | ▼ Sale | 11,511 | $3.87 | $45K | -2.4% | plan |
| Feb 24, 2026 | Swartz RobinCOO & CBO · O | ▼ Sale | 6,458 | $3.77 | $24K | -3.1% | plan |
| Feb 24, 2026 | Sandrock AlfredPresident and CEO · O·D | ▼ Sale | 14,197 | $3.79 | $54K | -2.8% | plan |
| Feb 24, 2026 | Jorgensen Nathan D.Chief Financial Officer · O | ▼ Sale | 4,668 | $3.77 | $18K | -3% | plan |
| Feb 24, 2026 | Carter Todd AlfredChief Scientific Officer · O | ▼ Sale | 4,174 | $3.76 | $16K | -2.8% | plan |
| Feb 18, 2026 | Swartz RobinCOO & CBO · O | ▼ Sale | 3,882 | $3.44 | $13K | -1.8% | plan |
| Feb 18, 2026 | Carter Todd AlfredChief Scientific Officer · O | ▼ Sale | 3,301 | $3.44 | $11K | -2.2% | plan |
| Feb 18, 2026 | Sandrock AlfredPresident and CEO · O·D | ▼ Sale | 11,732 | $3.41 | $40K | -2.3% | plan |
| Feb 10, 2026 | Swartz RobinCOO & CBO · O | ▼ Sale | 4,569 | $3.85 | $18K | -2.1% | — |
| Feb 10, 2026 | Sandrock AlfredPresident and CEO · O·D | ▼ Sale | 12,192 | $3.78 | $46K | -2.3% | — |
| Feb 10, 2026 | Carter Todd AlfredChief Scientific Officer · O | ▼ Sale | 3,525 | $3.85 | $14K | -2.2% | — |
| Oct 3, 2025 | Jorgensen Nathan D.Chief Financial Officer · O | ▼ Sale | 7,666 | $4.78 | $37K | -5.8% | plan |
| Aug 18, 2025 | Ferguson TobyChief Medical Officer · O | ▼ Sale | 19,000 | $3.73 | $71K | -12% | — |
Every $VYGR filing on this page is one API call away
The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? Voyager Therapeutics filings can reach your inbox instead.
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $VYGR feed.